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Dental pulp/dentin regeneration using dental stem cells combined with odontogenic factors may offer
great promise to treat and/or prevent premature tooth loss. Here, we investigate if BMP9 and Wnt/b-
catenin act synergistically on odontogenic differentiation. Using the immortalized SCAPs (iSCAPs) iso-
lated from mouse apical papilla tissue, we demonstrate that Wnt3A effectively induces early osteogenic
marker alkaline phosphatase (ALP) in iSCAPs, which is reduced by b-catenin knockdown. While Wnt3A
and BMP9 enhance each other's ability to induce ALP activity in iSCAPs, silencing b-catenin signiﬁcantly
diminishes BMP9-induced osteo/odontogenic differentiation. Furthermore, silencing b-catenin reduces
BMP9-induced expression of osteocalcin and osteopontin and in vitro matrix mineralization of iSCAPs.
In vivo stem cell implantation assay reveals that while BMP9-transduced iSCAPs induce robust ectopic
bone formation, iSCAPs stimulated with both BMP9 and Wnt3A exhibit more mature and highly
mineralized trabecular bone formation. However, knockdown of b-catenin in iSCAPs signiﬁcantly di-
minishes BMP9 or BMP9/Wnt3A-induced ectopic bone formation in vivo. Thus, our results strongly
suggest that b-catenin may play an important role in BMP9-induced osteo/ondontogenic signaling and
that BMP9 and Wnt3A may act synergistically to induce osteo/odontoblastic differentiation of iSCAPs. It's
conceivable that BMP9 and/or Wnt3A may be explored as efﬁcacious biofactors for odontogenic
regeneration and tooth engineering.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).atory, The University of Chi-
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Teeth are highly mineralized organs resulting from sequential
and reciprocal interactions between the oral epithelium and the
underlying cranial neural crest-derived mesenchyme [1e3]. Pre-
mature tooth loss caused by caries, pulpitis, and apical periodontitis
presents a formidable challenge in managing the patient's quality
of life, and controlling health care costs and loss of economic pro-
ductivity. While de novo tooth engineering may provide greatnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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nessing the natural regenerative potential of dental stem cells in
dentin-pulp tissues may offer more practical solutions to enhance
wound healing and maintain pulp vitality [4e6]. Any successful
tissue engineering would require at least three components,
including bio-compatible scaffolding materials, effective biological
factors, and progenitors that have differentiation potential of
becoming intended tissue types. Most of dental structures are
derived from dental ectomesenchyme, a zone of condensed cells
derived from oral ectoderm during embryonic tooth development
[1,4,7]. Dental stem cells are considered a population of mesen-
chymal stem cell (MSC)-like cells, and at least ﬁve types of dental
stem/progenitor cells have been identiﬁed [1,7], including dental
pulp stem cells (DPSCs), stem cells from human exfoliated decid-
uous teeth (SHED), periodontal ligament stem cells (PDLSCs),
dental follicle progenitor cells (DFPCs), and stem cells from apical
papilla (SCAP). Although these postnatal populations have MSC-
like characteristics, the dental stem cells are isolated from
specialized tissues with potent capacities to differentiate into
odontogenic cells.
We have recently established a reversibly immortalized mouse
stem cells of apical papilla tissue of mouse lower incisor teeth (or
iSCAPs), which not only maintain long-term cell proliferation but
also retain the ability to differentiate into multiple lineages,
including osteo/odontoblastic lineage upon BMP9 stimulation [8].
We previously demonstrated that BMP9 (aka, growth and differ-
entiation factor 2, or GDF2) is one of the most potent factors that
can induce osteogenic and adipogenic, to a lesser extent, chon-
drogenic differentiation of MSCs [9e13]. However, it remains to be
thoroughly investigated how odontogenic differentiation is regu-
lated by other major signaling pathways, such as Wnt/b-catenin.
Wnts are a family of secreted glycoproteins that regulate many
developmental processes [14e16]. Wnt signaling plays an impor-
tant role in skeletal development [15,17e20]. Wnt proteins bind to
their cognate receptor frizzled (Fz) and LRP-5/6 co-receptors, and
activate distinct signaling pathways, including the canonical b-
catenin pathway. In the absence of Wnt signaling, b-catenin is
degraded by the proteasome system after GSK3b dependent
phosphorylation. In the presence of Wnt signaling, unphosphory-
lated b-catenin accumulates in the cytoplasm and translocates into
the nucleus where it associates with Tcf/LEF transcription factors to
regulate the expression of target genes [16,21e24]. However, the
precise function of Wnt/b-catenin in osteo/odontoblastic differen-
tiation remains to be fully elucidated.
In this study, we investigate the effect of Wnt/b-catenin
signaling on osteo/odontogenic differentiation of iSCAP cells, and
the role of b-catenin in mediating the synergistic effect between
BMP9 and Wnt3A on osteo/odontogenic differentiation. Using a
stable iSCAP line in which b-catenin expression was effectively
silenced, we found that Wnt3A induces early osteogenic marker
alkaline phosphatase (ALP) in iSCAP cells, which can be signiﬁ-
cantly diminished by b-catenin knockdown. While Wnt3A and
BMP9 enhance each other's ability to induce ALP activity in iSCAPs,
silencing b-catenin signiﬁcantly diminishes the BMP9-induced
osteo/odontogenic, but not adipogenic, differentiation. Silencing
b-catenin leads to a decrease in BMP9-induced expression of
osteocalcin and osteopontin and in vitro matrix mineralization of
the iSCAPs. In vivo stem cell implantation assay reveals that, while
BMP9-transduced iSCAP cells induce robust ectopic bone forma-
tion, the iSCAP cells stimulated with both BMP9 andWnt3A exhibit
more mature and highly mineralized trabecular bone formation.
However, knockdown of b-catenin in iSCAP cells signiﬁcantly in-
hibits BMP9 or BMP9/Wnt3A-induced ectopic bone formation
in vivo. These results strongly suggest that b-catenin signaling may
play an important role in BMP9-induced osteo/ondontogenicsignaling and that BMP9 and Wnt3A may act synergistically to
induce osteo/odontoblastic differentiation of iSCAPs, which re-
quires functional b-catenin signaling activity. Thus, it's conceivable
that BMP9 and/or Wnt3A may be explored as novel and efﬁcacious
biofactors for odontogenic regeneration and tooth engineering.
2. Materials and methods
2.1. Cell culture and chemicals
HEK-293 cell line was purchased from ATCC (Manassas, VA) and maintained in
complete Dulbecco's Modiﬁed Eagle's Medium (DMEM) containing 10% fetal bovine
serum (FBS, Invitrogen, Carlsbad, CA), 100 units of penicillin and 100 mg of strep-
tomycin at 37 C in 5% CO2 [25e30]. The immortalized mouse stem cells of dental
apical papilla (iSCAPs) were previously characterized and reported [8]. The recently
engineered 293pTP line was used for adenovirus ampliﬁcation [31]. Both 293pTP
and iSCAPs were maintained in complete DMEM. Unless indicated otherwise, all
chemicals were purchased from SigmaeAldrich (St. Louis, MO) or Fisher Scientiﬁc
(Pittsburgh, PA).
2.2. Construction of the piggyBac vector expressing three siRNA sites targeting
mouse b-catenin and the generation of stable iSCAP-KD and iSCAP-Ctrl lines
Using the three siRNA targeting sites that were previously proven effective
[32,33], we subcloned three siRNA sites, each driven by the opposing U6 and H1
promoters into our modiﬁed piggyBac transposon vector pMPB [26,28], yielding
pMPB-simBC. All cloning fragments were veriﬁed by DNA sequencing. A vector
containing the scrambled sites was also constructed as a control (e.g., pMPB-Ctrl).
Subconﬂuent iSCAP cells were co-transfected with the above vectors and a piggy-
Bac transposase-expressing vector [26,28]. At 48 h after transfection, the cells were
selected against blasticidin S (4 mg/ml) for 5e7 days. The resultant stable lines were
designated as iSCAP-KD and iSCAP-Ctrl, respectively.
2.3. Generation and ampliﬁcation of recombinant adenoviruses expressing BMP9,
Wnt3A, and GFP
Recombinant adenoviruses were generated using the AdEasy technology as
described [9,10,12,34]. The coding regions of human BMP9 and mouse Wnt3A were
PCR ampliﬁed and cloned into an adenoviral shuttle vector, and subsequently used
to generate and amplify recombinant adenoviruses in HEK-293 or 293pTP cells [31].
The resulting adenoviruses were designated as AdBMP9 and AdWnt3A, both of
which also express GFP [35e38]. Analogous adenovirus expressing only GFP
(AdGFP) was used as controls [33,39e41]. For all adenoviral infections, polybrene
(4e8 mg/ml) was added to enhance infection efﬁciency as previously reported [29].
2.4. Cell transfection and ﬁreﬂy luciferase assay
Subconﬂuent iSCAP cells were transfected with the Tcf/Lef reporter pTOP-Luc
using Lipofectamine Reagent (Invitrogen) by following the manufacturer's in-
structions. At the end of transfection procedure, the cells were infected with
AdWnt3A or AdGFP. At 48 h post transfection/infection, cells were lysed for lucif-
erase assays using Luciferase Assay System (Promega, Madison, WI) by following the
manufacturer's instructions. Easy conditions were done in triplicate.
2.5. RNA isolation, quantitative and semi-quantitative RT-PCR (qPCR & sqPCR)
Total RNA was isolated by using TRIZOL Reagents (Invitrogen) and used to
generate cDNA templates by reverse transcription reactions with hexamer and M-
MuLV reverse transcriptase (New England Biolabs, Ipswich, MA). The cDNA products
were used as PCR templates. The sqPCR were carried out as described [42e46]. PCR
primers (Suppl. Table 1) were designed by using the Primer3 program and used to
amplify the genes of interest (approximately 150e250 bp).
For qPCR analysis, SYBR Green-based qPCR analysis was carried out by using the
thermocycler Opticon II DNA Engine (Bio-Rad, CA) with a standard pUC19 plasmid as
described elsewhere [27,47e49]. The qPCR reactions were done in triplicate. The
sqPCR was also carried out as described [30e32,39,46,50e53]. Brieﬂy, sqPCR re-
actions were carried out by using a touchdown protocol: 94C  2000 , 68C  3000 ,
70C  2000 for 12 cycles, with 1 C decrease per cycle, followed by 25e30 cycles at
94C  2000 , 56C  3000 , 70C  2000 . PCR products were resolved on 1.5% agarose
gels. All samples were normalized by the expression level of GAPDH.
2.6. Immunoﬂuorescence staining
Immunoﬂuorescence staining was performed as described [12,33,42,49,54,55].
Brieﬂy, cells were infected with AdWnt3A or AdGFP for 48 h, ﬁxed with methanol,
permeabilized with 1% NP-40, and blocked with 10% BSA, followed by incubating
with b-catenin antibody (Santa Cruz Biotechnology). After being washed, cells were
incubated with Texas Red-labeled secondary antibody (Santa Cruz Biotechnology).
Stains were examined under a ﬂuorescence microscope. Stains without primary
antibodies, or with control IgG, were used as negative controls.
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ALP activity was assessed quantitatively with a modiﬁed assay using the Great
Escape SEAP Chemiluminescence assay kit (BD Clontech, Mountain View, CA) and
qualitatively with histochemical staining assay (using a mixture of 0.1 mg/ml nap-
thol AS-MX phosphate and 0.6 mg/ml Fast Blue BB salt), as described
[9,10,12,33,39,43,51,54]. Each assay condition was performed in triplicate and the
results were repeated in at least three independent experiments. ALP activity was
normalized by total cellular protein concentrations among the samples.Fig. 1. Construction and validation of siRNAs targeting mouse b-catenin in the iSCAPs. (A) Sc
sequences and locations of the three siRNA sites (simBC1, 2, and 3) on mouse b-catenin ope
iSCAPs. Total RNA was isolated form subconﬂuent iSCAP cells that were stably transduced w
(iSCAP-Ctrl). The RNA samples were subjected to reverse-transcription and subsequently qua
The relative b-catenin expression level was calculated by dividing the b-catenin concentrat
simBCs can effectively block Wnt3a-induced b-catenin accumulation. Subconﬂuent iSCAP
subjected to immunoﬂuorescence staining with an anti-b-catenin antibody.2.8. Matrix mineralization assay (alizarin red S staining)
iSCAP cells were seeded in 24-well cell culture plates and infected with AdBMP9
or AdGFP. Infected cells were cultured in the presence of ascorbic acid (50 mg/mL)
and b-glycerophosphate (10 mM). At 10 days after infection, mineralized matrix
nodules were stained for calcium precipitation with Alizarin Red S as described
[9,10,12,33,39,43,51,54]. Brieﬂy, cells were ﬁxed with 0.05% (v/v) glutaraldehyde at
room temperature for 10 min and washed with distilled water, ﬁxed cells were
incubated with 0.4% Alizarin Red S (SigmaeAldrich) for 5 min, followed by extensivehematic representation of the tandem siRNA targeting conﬁguration and the targeting
n reading frame (ORF). (B) Efﬁcient knockdown of endogenous b-catenin expression in
ith the piggyBac vector expressing three simBC sites (iSCAP-KD) or scrambled controls
ntitative real-time PCR (qPCR) using primers speciﬁc for mouse b-catenin and GAPDH.
ion with the respective GAPDH concentration. Each reaction was done in triplicate. (C)
-KD and iSCAP-Ctrl cells were infected with AdWnt3A or AdGFP for 30 h, ﬁxed and
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under bright ﬁeld microscopy.2.9. Oil red O staining assay
iSCAPs were seeded in 12-well cell culture plates and infected with AdBMP9 or
AdGFP for 10 days. Oil Red O staining was performed as described [12,52]. Brieﬂy,
cells were ﬁxed with 10% formalin at room temperature for 20min and washed with
PBS. The ﬁxed cells were stained with freshly prepared Oil Red-O solution (6 parts
saturated Oil Red O dye in isopropanol plus 4 parts water) at 37 C for 30e60 min,
followed by washing with 70% ethanol and distilled water.2.10. iSCAP cell implantation, ectopic bone formation, and micro-computed
tomography (mCT) analysis
All animal studies were conducted by following the guidelines approved by the
Institutional Animal Care and Use Committee (IACUC). Stem cell-mediated ectopic
bone formation was performed as described [10,12,26,46,51,53,56e58]. Brieﬂy,
iSCAP cells were infected with AdBMP9 and/or AdWnt3A, or AdGFP for 16 h,
collected and resuspended in PBS for subcutaneous injection (5106/injection) into
the ﬂanks of athymic nude (nu/nu) mice (5 animals per group, 4e6 wk old, female,
Harlan Laboratories, Indianapolis, IN). At 4 weeks after implantation, animals were
sacriﬁced, and the implantation sites were retrieved for mCT imaging, histologic
evaluation, and special stains. All retrieved specimens were ﬁxed and imaged using
the mCT component of a GE triumph (GE healthcare, Piscataway, NJ) trimodality
preclinical imaging system. All image data analysis was performed using Amira 5.3
(Visage Imaging, Inc., San Diego, CA), and 3D volumetric data were obtained as
described [8,26,43,46,52,53,56,57].2.11. Histological evaluation and Trichrome staining
Retrieved tissues were ﬁxed, decalciﬁed in 10% buffered formalin, and
embedded in parafﬁn. Serial sections of the embedded specimens were stained with
hematoxylin and eosin (H & E). Trichrome staining was carried out as previously
described [9,10,12,26].2.12. Statistical analysis
The quantitative assays were performed in triplicate and/or repeated three
times. Data were expressed as mean ± SD. Statistical signiﬁcances were determined
by one-way analysis of variance and the student's t test. A value of p < 0.05 was
considered statistically signiﬁcant.Fig. 2. The iSCAP-KD cells are signiﬁcantly less responsive to Wnt3A-activated ca-
nonical signaling pathway. (A) iSCAP-KD cells exhibit signiﬁcantly lower b-catenin/Tcf
reporter activity upon Wnt3A stimulation. Subconﬂuent iSCAP-KD and iSCAP-Ctrl cells
were transfected with TOP-Luc reporter plasmid and infected with AdWnt3A or AdGFP.
At 48 h post transfection/infection, cells were lysed for luciferase assays. Easy condi-
tions were done in triplicate. (B).Wnt3A-induced expression of Wnt/b-catenin target
genes was signiﬁcantly decreased in iSCAP cells. Subconﬂuent iSCAP-KD and iSCAP-Ctrl
cells were infected with AdWnt3A or AdGFP for 36 h. Total RNA was isolated and
subjected to reverse transcription. The resultant cDNAs were used as templates for
qPCR analysis using primers speciﬁc for mouse Axin2 and c-Myc transcripts. All
samples were normalized by GAPDH levels. Each assay condition was done in
triplicate.3. Results
3.1. Construction and validation of siRNAs targeting mouse b-
catenin in iSCAPs
We have recently demonstrated that piggyBac transposon sys-
tem has signiﬁcant advantages over retroviral vectors in terms of
generating high expression stable lines [26,28]. In order to effec-
tively and stably silence mouse b-catenin expression in iSCAP cells,
we subcloned three siRNA sites (Fig. 1A), each driven by the
opposing U6 and H1 promoters into our modiﬁed piggyBac pMPB
[26,28], yielding pMPB-simBC. A vector containing the scrambled
sites was also constructed as a control (e.g., pMPB-Ctrl). Subcon-
ﬂuent iSCAP cells were co-transfected with the above vectors and a
piggyBac transposase-expressing vector [26,28]. Stable lines were
obtained by selecting them against blasticidin S and designated as
iSCAP-KD and iSCAP-Ctrl, respectively.
We ﬁrst assessed the knockdown efﬁciency of endogenous b-
catenin in iSCAP cells. Using qPCR analysis, we found that the
endogenous b-catenin expression in the iSCAP-KD cells was
approximately 5% of that in the iSCAP-Ctrl cells (Fig. 1B), indicating
that the endogenous b-catenin expression is effectively silenced in
the iSCAP-KD cells. Furthermore, when iSCAP-KD cells were
transduced with Wnt3A, we found that cytoplasmic/nuclear accu-
mulation of b-cateninwas signiﬁcantly diminished, compared with
that in the iSCAP-Ctrl cells (Fig. 1C). Thus, these results strongly
demonstrate that b-catenin expression is effectively silenced in the
iSCAP-KD cells.3.2. iSCAP-KD cells are signiﬁcantly less responsive to Wnt3A-
activated canonical signaling pathway
We further analyzed the effect of b-catenin knockdown on the
downstream events of Wnt/b-catenin signaling in iSCAP cells.
When subconﬂuent iSCAP-KD and iSCAP-Ctrl cells were transfected
with TOP-Luc reporter plasmid and infected with AdWnt3A or
AdGFP, we found that the relative reporter activity in Wnt3A-
stimulated iSCAP-KD cells decreased to approximately 22% of that
of the iSCAP-Ctrl cells (Fig. 2A). Accordingly, when the expression of
two well-characterized Wnt/b-catenin downstream target genes,
Axin2 [59] and c-Myc [21], was examined, we found that Wnt3A
was shown to signiﬁcantly induce the expression of Axin2 and c-
Myc in iSCAP-Ctrl cells, which was effectively inhibited in iSCAP-KD
cells (Fig. 2B). These results strongly suggest that knocking down b-
catenin expression in ISCAP-KDmay effectively blunt the functional
activities of canonical Wnt signaling.3.3. Silencing b-catenin expression signiﬁcantly diminishes BMP9-
induced osteo/odontoblastic differentiation of iSCAP cells
We and others demonstrated that canonical Wnt signaling can
effectively induce osteogenic differentiation of mesenchymal stem
cells [20,33,39,47]. We sought to determine if Wnt3A can induce
early osteo/odontogenic marker alkaline phosphatase (ALP) activity
in iSCAPs, and if the induced ALP activity would be reduced when
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tively induced ALP activity in iSCAP-Ctrl cells, which was signiﬁ-
cantly blunted in iSCAP-KD cells (Fig. 3A). Accordingly, quantitative
ALP assays indicate that Wnt3A induced ALP activity in a dose-
dependent fashion (at least at day 3) in iSCAP-Ctrl cells (Fig. 3B,
panel a) while b-catenin knockdown in iSCAP-KD cells signiﬁcantly
decreased ALP activity, compared to that in iSCAP-Ctrl cells
(p < 0.001) (Fig. 3B, panels a & b), suggesting that Wnt3A-induced
oste/odonotoblastic differentiation of iSCAPs requires functional b-
catenin.
We previously demonstrated that BMP9 is one of the most
potent osteogenic BMPs in mesenchymal cell stems and in iSCAPs
[8e12]. We sought to test if silencing b-catenin affects BMP9-
induced oste/odonotoblastic differentiation of iSCAPs. We found
that BMP9 stimulated robust ALP activity qualitatively in iSCAP-
Ctrl cells while the BMP9-induced ALP activity was remarkably
reduced in iSCAP-KD cells (Fig. 4A). Quantitatively, BMP9 was
shown to induce ALP activity in a dose-dependent fashion in both
iSCAP-Ctrl and iSCAP-KD cells although the ALP activity was
signiﬁcantly lower in iSCAP-KD cells than that in iSCAP-Ctrl cells
at each of the four titers tested (p < 0.001) (Fig. 4B). We further
tested the late stage mineralization in BMP9-stimulated iSCAP
cells and found that Alizarin red staining was markedly decreased
in iSCAP-KD cells compared with that in iSCAP-Ctrl cells (Fig. 4C).
We previously demonstrated that BMP9 can induce adipogenic
differentiation of mesenchymal stem cells [12]. Oil red O staining
experiments indicate that BMP9 induced signiﬁcant adipogenic
differentiation in both iSCAP-KD and iSCAP-Ctrl cells, which is
seemingly not affected by b-catenin knockdown (Fig. 4D). These
results suggest that while Wnt3A itself can induce odontoblasticFig. 3. Silencing b-catenin expression reduces Wnt3A-induced early osteogenic marker alkal
in iSCAP-KD cells. Subconﬂuent iSCAP-KD and iSCAP-Ctrl cells were infected with AdWnt3
qualitative ALP activity at day 3. Each assay conditions were done in triplicate. Representa
fashion, which is blunted by silencing b-catenin expression in iSCAP cells. Subconﬂuent iS
ities of infection) of AdWnt3A or AdGFP. At the indicated time points post infection, cells we
were done in triplicate. “**”, p < 0.001 (iSCAP-KD vs. iSCAP-Ctrl).differentiation of iSCAPs functional b-catenin activity may be
essential for BMP9-induced osteo/odontogenic differentiation in
iSCAP cells.
3.4. Silencing b-catenin diminishes the synergistic osteo/
odontogenic activity between BMP9 and Wnt3A in iSCAP cells
We next examined if Wnt3A and BMP9 synergistically regulate
odontogenic differentiation of iSCAP cells and if b-catenin plays an
important role in this synergistic action. When iSCAP-Ctrl cells
were transduced with a ﬁxed titer of AdBMP9 and increasing titers
of AdWnt3A, there was an apparent trend of increasing ALP activ-
ities at both days 3 and 5 (p < 0.05) (Fig. 5A). However, ALP activities
were consistently lower in the iSCAP-KD cells under the same
conditions (Fig. 5A). Accordingly, when iSCAP-Ctrl cells were
transduced with a ﬁxed titer of AdWnt3A and increasing titers of
AdBMP9, there was a similar trend of increasing ALP activities at
higher Wnt3A titers, especially at day 5 (p < 0.05), while b-catenin
knockdown signiﬁcantly diminished the ALP activities induced by
BMP9 andWnt3A (Fig. 5B). Furthermore, both BMP9 and, to a lesser
extent, Wnt3A were shown to induce the expression of osteogenic
regulator Runx2 in iSCAP-Ctrl cells, which was signiﬁcantly
reduced in iSCAP-KD cells (p < 0.001) (Fig. 5C, panel a). The
expression of late osteogenic marker osteopontin (OPN) was
signiﬁcantly elevated in Wnt3A and/or Wnt3A stimulated iSCAP-
Ctrl cells, which was drastically diminished in iSCAP-KD cells
(p < 0.001) (Fig. 5C, panel b). These results strongly suggest that
BMP9 and Wnt3A may act synergistically to induce osteo/odonto-
blastic differentiation of iSCAPs, which requires functional b-cat-
enin activity.ine phosphatase (ALP) activity in iSCAP cells. (A) Wnt3A-induced ALP activity decreases
A or AdGFP. At the indicated time points post infection, cells were either stained for
tive staining results are shown. (B) Wnt3A induces ALP activity in a dose-dependent
CAP-KD and iSCAP-Ctrl cells were infected with the indicated titers (MOIs, multiplic-
re lysed for quantitative ALP activity assays at days 3 (a) or 5 (b). Each assay conditions
Fig. 4. Silencing b-catenin expression signiﬁcantly diminishes BMP9-induced osteo/odontoblastic differentiation of iSCAP cells. (A) and (B) BMP9-induced ALP activity is decreased
in the b-catenin silenced iSCAP cells. (A) ALP histochemical staining assay. Subconﬂuent iSCAP-KD and iSCAP-Ctrl cells were infected with AdBMP9 or AdGFP. At day 5 post infection,
cells were ﬁxed for ALP histochemical staining assay. Each assay conditions were done in triplicate. Representative results are shown. (B) Quantitative ALP assay. Subconﬂuent
iSCAP-KD and iSCAP-Ctrl cells were infected with the indicated titers (MOIs) of AdBMP9 or AdGFP. At day 5 post infection, cells were lysed for quantitative ALP activity assays. Each
assay conditions were done in triplicate. “**”, p < 0.001 (iSCAP-KD vs. iSCAP-Ctrl). (C) Alizarin red S staining. Subconﬂuent iSCAP-KD or iSCAP-Ctrl cells were infected with AdBMP9
or AdGFP, and maintained in matrix mineralization culture medium for 10 days. Matrix mineralization nodules were stained with Alizarin Red S as described in Methods. Staining
results were recorded under a microscope. (D) Oil Red O staining. Subconﬂuent iSCAP-KD or iSCAP-Ctrl cells were infected with AdBMP9 or AdGFP, and cultured for 10 days. Oil Red
O staining was performed as described in Methods. All staining experiments were carried out in duplicate. Representative images are shown. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
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potentiated by Wnt3A but attenuated by b-catenin knockdown
Using our previously established stem cell implantation assay
[8,12,26,38,46,52,53,58], we tested the in vivo effect of BMP9 and
Wnt3A signaling crosstalk on ectopic bone formation of iSCAP cells.
Subconﬂuent iSCAP-KD and iSCAP-Ctrl cells were transduced with
AdBMP9, AdWnt3A, AdBMP9þAdWnt3A, or AdGFP, and injected
subcutaneously into the ﬂanks of athymic nude mice for 4 weeks.
No recoverable masses were detected in the GFP or Wnt3A group.
Robust bony masses were retrieved from both BMP9 and
BMP9þWnt3A transduced iSCAP-Ctrl groups while much smaller
masses were recovered from the iSCAP-KD cells (Fig. 6A, panel a).
MicroCT imaging illustrated more distinct size differences among
these samples (Fig. 6A, panel b). Quantitative analysis of the total
bone volumes indicates that in iSCAP-Ctrl cells co-transduction of
BMP9 and Wnt3A induced signiﬁcantly more robust boneformation than that transduced with BMP9 alone (Fig. 6A, panel c),
suggesting that Wnt3A may potentiate BMP9-induced bone for-
mation even though Wnt3A itself failed to induce any ectopic bone
formation. However, in iSCAP-KD cells either BMP9 or
BMP9 þ Wnt3A-induced bone formation was signiﬁcantly dimin-
ished when compared with that in iSCAP-Ctrl cells (p < 0.001)
(Fig. 6A, panel c). Accordingly, H & E histological evaluation
revealed that BMP9-transduced iSCAP-Ctrl cells formed evident
trabecular bone, which was even more robust in the presence of
both BMP9 andWnt3A (Fig. 6B, two left panels). Silencing b-catenin
expression in iSCAP-KD cells, however, signiﬁcantly reduced
trabecular bone formation induced by BMP9 or BMP9þWnt3A
(Fig. 6B). Trichrome staining conﬁrmed that iSCAP-Ctrl cells
transduced with BMP9 formed apparently mature and mineralized
bone matrices, while a combination of BMP9 and Wnt3A induced
more mature and highly mineralized bone matrices (Fig. 6C, two
left panels). However, the maturity and mineralization were
Fig. 5. Silencing b-catenin diminishes the synergistic osteogenic activity between BMP9 and Wnt3A in iSCAP cells. (A) Increased exogenous Wnt3A expression does not completely
recover the BMP9-induced osteogenic activity in iSCAP-KD cells. Subconﬂuent iSCAP-KD and iSCAP-Ctrl cells were co-infected a ﬁxed titer of AdBMP9 and/or varied titers of
AdWnt3A or AdGFP. ALP activity was assayed on days 3 and 5. Each assay conditions were done in triplicate. The net ALP activity was calculated by subtracting ALP readings of BMP9
or Wnt3A only groups from that of respective BMP9þWnt3A groups. “*”, p < 0.05; “**”, p < 0.001 (iSCAP-KD vs. iSCAP-Ctrl). (B) Increased exogenous BMP9 expression fails to
overcome the decrease of BMP9-induced osteogenic activity in iSCAP-KD cells. Subconﬂuent iSCAP-KD and iSCAP-Ctrl cells were co-infected a ﬁxed titer of AdWnt3A and/or varied
titers of AdBMP9 or AdGFP. ALP activity was assayed on days 3 and 5. Each assay conditions were done in triplicate. The net ALP activity was calculated by subtracting ALP readings
of the BMP9 or Wnt3A only groups from that of respective BMP9þWnt3A groups. “*”, p < 0.05; “**”, p < 0.001 (iSCAP-KD vs. iSCAP-Ctrl). (C) Wnt3A and/or BMP9-induced expression
of bone speciﬁc markers is signiﬁcantly decreased in b-catenin silenced iSCAP cells. Subconﬂuent iSCAP-KD and iSCAP-Ctrl cells were infected with AdGFP, AdWnt3A, AdBMP9, or
AdBMP9þAdWnt3A for 5 days. Total RNA was isolated and subjected to reverse transcription and quantitative real-time PCR using primers speciﬁc for mouse Runx2 (a) or
osteopontin (OPN) (b), as well as GAPDH. Relative expression level was calculated by dividing Runx expression levels with respective GAPDH expression levels. Each assay condition
was done in triplicate. “**”, p < 0.001 (iSCAP-KD vs. iSCAP-Ctrl).
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BMP9 or BMP9þWnt3A (Fig. 6C). Taken together, these in vivo re-
sults strongly suggest that b-catenin may play an important role in
mediating BMP9-induced bone formation, and the BMP9-Wnt3A
may crosstalk in inducing osteo/odontoblastic differentiation of
iSCAP cells.
4. Discussion
To understand how major signaling pathways regulate osteo/
odontogenic differentiation, we investigated if canonical Wnt/b-
catenin signaling plays an important role in BMP9-induced osteo/
odontogenic signaling in iSCAPs. By leveraging the efﬁcient trans-
duction efﬁciency of our modiﬁed piggyBac transposon system, we
established a stable iSCAP line in which b-catenin expression was
efﬁciently silenced. Using this knockdown and control lines we
demonstrated that Wnt3A induced early osteogenic marker ALP in
iSCAP cells, which was signiﬁcantly diminished by b-catenin
knockdown.While Wnt3A and BMP9 promoted each other's ability
to induce ALP activity, silencing b-catenin signiﬁcantly diminishes
the BMP9-induced osteo/odontogenic, but not adipogenic, differ-
entiation of iSCAP cells. Moreover, silencing b-catenin led to a
decrease in BMP9-induced expression of osteocalcin and osteo-
pontin and in vitromatrix mineralization of the iSCAP cells. In vivo
studies revealed that while BMP9-transduced iSCAP cells inducedrobust ectopic bone formation, the iSCAP cells stimulated with both
BMP9 and Wnt3A exhibited more mature and highly mineralized
trabecular bone formation. Knockdown of b-catenin in iSCAP cells
signiﬁcantly inhibited BMP9 or BMP9/Wnt3A-induced ectopic
bone formation in vivo. These results strongly suggest that canon-
ical Wnt/b-catenin signaling may play an important role in BMP9-
induced osteo/ondontogenic signaling and that BMP9 and Wnt3A
may act synergistically to induce osteo/odontoblastic differentia-
tion of iSCAPs, which requires functional b-catenin signaling
activity.
While the detailed molecular mechanisms underlying tooth
development remain to be fully elucidated, it's well established that
the interactions between the epithelial and mesenchymal tissue
components of developing teeth regulate morphogenesis and cell
differentiation, and determine key features of dentitions and indi-
vidual teeth, such as the number, size, shape, and formation of
dental hard tissues [60e62]. It is generally accepted that several
conserved signaling pathways, including the BMP, Wnt, FGF, Shh
and Notch pathways, play important roles throughout tooth
development [60e62]. These signaling pathways may interact or
crosstalk through positive and negative feedback loops to regulate
not only morphogenesis of individual teeth but also tooth number,
shape, and spatial pattern [61,62]. For example, it has been reported
that cessation of epithelial BMP signaling switches the differenti-
ation of crown epithelia to the root lineage in a b-catenin-
Fig. 6. BMP9-induced ectopic bone formation from iSCAP cells is potentiated by Wnt3A but attenuated by b-catenin knockdown. Subconﬂuent iSCAP-KD and iSCAP-Ctrl cells were
infected with AdBMP9, AdWnt3A, AdBMP9þAdWnt3A, or AdGFP for 16 h. Cells were collected for subcutaneous injections (3  106 cells/site in 100 ml PBS) into the ﬂanks of athymic
nude mice (n ¼ 5 each group). (A) Gross images and mCT analysis. At 4 weeks after injection, the animals were sacriﬁced. Masses formed at the injection sites were retrieved (a),
ﬁxed in formalin, and subjected to mCT imaging (b). No masses were detected the animals injected with GFP-transduced iSCAPs. The 3-D reconstruction was performed for all
scanned samples (b), and the average total bone volume (c) were determined using the Amira 5.3 software. “**”, p < 0.001 when compared with that of the BMP9-transduced iSCAP-
Ctrl cells. (B) and (C) Histologic evaluation and Trichrome staining. After mCT imaging was completed, the samples were decalciﬁed and subjected to parafﬁn-embedded sectioning
for histologic evaluation, including H & E staining (B) and Trichrome staining (C). Representative results are shown. TB, trabecular bone; MBM, mineralized bone matrix; OM, osteoid
matrix.
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factor Epfn was shown to enhance canonical Wnt/b-catenin
signaling in the developing dental pulp mesenchyme, a condition
that promotes the activity of other downstream signaling path-
ways, such as BMPs, which are fundamental for cellular induction
and ameloblast differentiation [64]. It was reported that Wnt/b-
catenin signaling in the dental mesenchyme regulates incisor
development by regulating BMP4 [65]. It was reported that Smad4
may play a crucial role in regulating the interplay between TGFb/
BMP and Wnt signaling to ensure the proper cranial neural crest
cell fate during toothmorphogenesis [66]. A recent systems biology
analysis by integrating the epithelial and mesenchymal gene reg-
ulatory networks through the action of diffusible extracellular
signaling molecules identiﬁed a key epithelial-mesenchymal inter-
tissue Wnt-BMP feedback circuit [67].
While Wnt/b-catenin signaling has been shown to play an
essential role in activating odontogenic mesenchyme during early
tooth development and directing multiple stages of tooth
morphogenesis [68,69], little is known about possible roles of
BMP9 in tooth development. We have recently demonstrated that
BMP9 can effectively induce iSCAP cells to differentiate into bone,
cartilage, and, to lesser extent, adipocytes [8]. BMP9 (aka, GDF2) is
one of the least characterized BMPs and yet found by us as one of
the most potent oetsogenic BMPs [9e12,70,71]. We have recently
compared potentially important downstream mediators of Wnt3Aand BMP9 induced osteogenic differentiation inMSCs through gene
expression proﬁling, and found that Wnt3A and BMP9 regulated
the expression of overlapping but distinct sets of downstream
target genes [39,47], suggesting that there may be an important
crosstalk between BMP and Wnt-induced osteogenic signaling
pathways. We later demonstrated that canonical Wnt signaling,
possibly through b-catenin interaction with Runx2, plays an
important role in BMP9-induced osteogenic differentiation of MSCs
[33]. In this study, using the immortalized SCAPs isolated from the
apical papilla tissue of mouse lower incisor teeth we demonstrated
that Wnt3A and BMP9 can potentiate each other's ability to induce
osteo/odontogenic differentiation in vitro and in vivo. Furthermore,
b-catenin knockdown signiﬁcantly diminishes BMP9-induced
osteo/odontogenic differentiation of iSCAP cells, indicating that
BMP9-induced odontoblastic differentiation requires functional b-
catenin signaling. Interestingly, a recent study also found that
Wnt3a can enhance BMP9-induced osteogenic differentiation in
mesenchymal stem cell-like C3H10T1/2 cells [72]. However, this
study did not address if functional canonical Wnt signaling is
required for optimal BMP9-induced osteogenic differentiation.
Furthermore, our studies have expanded BMP9's odontogenic ac-
tivity in dental stem cells. Nonetheless, our work and others'
studies strongly suggest that the synergistic effect between Wnt3a
and BMP9 on osteogenesis may underline a commonmechanism in
the different types of osteogenic progenitor cells.
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between BMP9 and Wnt3A in odontogenic differentiation of iSCAP
cells. Although the molecular mechanisms behind this crosstalk are
largely undeﬁned, it was reported that b-catenin and Lef1/Tcf can
form a complex with Smad4 and/or Smad1 [73e76]. It was also
shown that Runx2 formed a complex with Lef1/Tcf4 and regulated
downstream target genes [77,78]. However, the signaling crosstalk
may be more complicated, as Lef-1 was found to repress the
osteocalcin promoter via interaction with Runx2 [79]; and it has
also been reported that canonical Wnt signaling promotes osteo-
genesis by directly stimulating Runx2 expression [80]. We have
recently demonstrated that BMP9 can induce the recruitment of
both Runx2 and b-catenin to the osteocalcin promoter in MSCs,
suggesting that canonical Wnt signaling, possibly through in-
teractions between b-catenin and Runx2, may play an important
role in BMP9-induced osteogenic differentiation of MSCs [33].
Nonetheless, the molecular mechanism underlying the crosstalk
between BMP9 and canonical Wnt/b-catenin in iSCAPs needs to be
further investigated.
We have demonstrated that the dental stem cells SCAPs retain
multipotent potential of differentiating into osteo/odontoblastic,
chondrogenic and adipogenic lineages. BMP9 can effectively induce
osteo/odontoblastic differentiation, which can be further potenti-
ated by canonical Wnts, such as Wnt3A. The b-catenin may play an
essential role in mediating such synergistic crosstalk effect be-
tween BMP9 andWnt3A. Thus, it is conceivable that a combination
of SCAPs (as a valuable progenitor source) and BMP9 andWnt3A (as
efﬁcacious biofactors) may allow us to achieve potentially suc-
cessful dental tissue engineering for odontogenic regeneration.
5. Conclusions
Using the immortalized SCAPs isolated from the apical papilla
tissue of mouse lower incisor teeth, we demonstrated that BMP9-
induced osteo/odontogenic differentiation can be potentiated by
Wnt3A in vitro and in vivo, but signiﬁcantly diminished by b-cat-
enin knockdown, suggesting that b-catenin may play an important
role in BMP9-induced osteo/ondontogenic signaling and that BMP9
and Wnt3A may act synergistically to induce osteo/odontoblastic
differentiation of iSCAPs. Thus, it's conceivable that BMP9 and/or
Wnt3A may be explored as novel and efﬁcacious biofactors for
odontogenic regeneration and tooth engineering.
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